Literature DB >> 14006539

Fatal marrow aplasia during chlorpropamide therapy.

L L WHITE.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/toxicology; BONE MARROW/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 14006539      PMCID: PMC1958082          DOI: 10.1136/bmj.1.5279.691

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Thrombocytopenia in a patient taking chlorpropamide.

Authors:  W J GRACE
Journal:  N Engl J Med       Date:  1959-04-02       Impact factor: 91.245

2.  Blood dyscrasias associated with tolbutamide therapy.

Authors:  F JOST
Journal:  J Am Med Assoc       Date:  1959-03-28

3.  Fatal agranulocytosis following chlorpropamide treatment of diabetes. Report of a case.

Authors:  H KARLIN
Journal:  N Engl J Med       Date:  1960-05-26       Impact factor: 91.245

  3 in total
  2 in total

1.  [THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].

Authors:  F J TRAISSAC; C BERAUD; J DANGOUMAU
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  Haemolysis and agranulocytosis complicating treatment with methyldopa.

Authors:  K G Clark
Journal:  Br Med J       Date:  1967-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.